目录:MedChemExpress LLC>>生化试剂>> Concizumab | MCE
CAS | 1312299-39-0 | 供货周期 | 现货 |
---|---|---|---|
规格 | 5 mg | 货号 | HY-P99283 |
应用领域 | 医疗卫生,化工,生物产业,制药/生物制药 |
MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务。
CAS No. : 1312299-39-0
产品活性:Concizumab is an anti-TFPI monoclonal antibody (IgG4 type) that binds to the Kunitz-type protease inhibitor (KPI) 2 structural domain of TFPI, thereby blocking the interaction of this structural domain with the FXa active site. Concizumab can be used in the study of haemophilia.
研究领域:Others
作用靶点:Others
In Vitro: Concizumab increases thrombin peak in a concentration- dependent manner.
In Vivo: Concizumab (i.v./s.c.) blocks the TFPI interaction with the active site of FXa in cynomolgus monkeys.
Parameter | Unit | Estimate | %RSE |
CLL | mL/h/kg | 0.14 | 6.1 |
V1 | mL/kg | 33 | 34 |
V2 | mL/kg | 33 | - |
Q | mL/h/kg | 0.12 | 16 |
F | % | 93 | 7.7 |
Vmax | µg/h/kg | 11 | 17 |
Km | µg/mL | 0.54 | 52 |
t1/2(abs) | h | 72 | 32 |